Literature DB >> 11771639

Investigation of the criminal and conditional release profiles of Canadian federal offenders as a function of psychopathy and age.

S Porter1, A R Birt, D P Boer.   

Abstract

Using the Psychopathy Checklist-Revised (PCL-R; R. D. Hare, 1991) diagnostic cut-off score of 30, the complete criminal career and community release profiles of 317 Canadian federal offenders (224 low scorers and 93 scoring within the psychopathic range) were investigated. Adult crimes were coded according to age at commission as well as either violent, nonviolent, or nonsexually violent. Changes in performance following release into the community also were examined. Results indicated that offenders scoring within the psychopathic range consistently committed more violent and nonviolent crimes than their counterparts for about three decades, spanning their late adolescence to their late 40s. Numbers of nonviolent criminal offenses committed by high PCL-R scorers declined considerably after age 30 relative to violent offenses, which declined and then rebounded in the late 30s before a major reduction was evidenced. Throughout adulthood, high PCL-R scorers failed during community release significantly faster than did low scorers. Importantly, from a risk management perspective, the release performance of low PCL-R scorers improved with age, whereas the opposite was seen for high scorers. Further, offenders scoring high on the PCL-R did not show a lower charge to conviction ratio with age, suggesting that they may not have been getting better at manipulating the legal system.

Entities:  

Mesh:

Year:  2001        PMID: 11771639     DOI: 10.1023/a:1012710424821

Source DB:  PubMed          Journal:  Law Hum Behav        ISSN: 0147-7307


  15 in total

1.  Psychopathy in Adolescence Predicts Official Reports of Offending in Adulthood.

Authors:  Donald R Lynam; Drew J Miller; David Vachon; Rolf Loeber; Magda Stouthamer-Loeber
Journal:  Youth Violence Juv Justice       Date:  2009-05-11

Review 2.  The Development of Severe and Chronic Violence Among Youth: The Role of Psychopathic Traits and Reward Processing.

Authors:  Dennis E Reidy; Elizabeth Krusemark; David S Kosson; Megan C Kearns; Joanne Smith-Darden; Kent A Kiehl
Journal:  Child Psychiatry Hum Dev       Date:  2017-12

Review 3.  Psychopathy: developmental perspectives and their implications for treatment.

Authors:  Nathaniel E Anderson; Kent A Kiehl
Journal:  Restor Neurol Neurosci       Date:  2014       Impact factor: 2.406

4.  Reducing psychopathic violence: A review of the treatment literature.

Authors:  Dennis E Reidy; Megan C Kearns; Sarah DeGue
Journal:  Aggress Violent Behav       Date:  2013 Sep-Oct

5.  Why psychopathy matters: Implications for public health and violence prevention.

Authors:  Dennis E Reidy; Megan C Kearns; Sarah DeGue; Scott O Lilienfeld; Greta Massetti; Kent A Kiehl
Journal:  Aggress Violent Behav       Date:  2015 Sep-Oct

6.  Validity of factors of the Psychopathy Checklist--Revised in female prisoners: discriminant relations with antisocial behavior, substance abuse, and personality.

Authors:  Patrick J Kennealy; Brian M Hicks; Christopher J Patrick
Journal:  Assessment       Date:  2007-12

7.  Brain response to empathy-eliciting scenarios involving pain in incarcerated individuals with psychopathy.

Authors:  Jean Decety; Laurie R Skelly; Kent A Kiehl
Journal:  JAMA Psychiatry       Date:  2013-06       Impact factor: 21.596

8.  The stability of psychopathy across adolescence.

Authors:  Donald R Lynam; Richard Charnigo; Terrie E Moffitt; Adrian Raine; Rolf Loeber; Magda Stouthamer-Loeber
Journal:  Dev Psychopathol       Date:  2009

Review 9.  Psychopathy and aggression: when paralimbic dysfunction leads to violence.

Authors:  Nathaniel E Anderson; Kent A Kiehl
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 10.  Psychopathy.

Authors:  Stephane A De Brito; Adelle E Forth; Arielle R Baskin-Sommers; Inti A Brazil; Eva R Kimonis; Dustin Pardini; Paul J Frick; Robert James R Blair; Essi Viding
Journal:  Nat Rev Dis Primers       Date:  2021-07-08       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.